UroGen Pharma Ltd Stock Forecast
UroGen Pharma Ltd stock price ended at $14.40 on Wednesday, after gaining 4.20%.
(Updated on May 01, 2024)
The UroGen Pharma Ltd stock price gained 4.20% on the last trading day (Wednesday, 1st May 2024), rising from $13.82 to $14.40. During the last trading day the stock fluctuated 5.47% from a day low at $13.89 to a day high of $14.65. The price has been going up and down for this period, and there has been a 1.12% gain for the last 2 weeks. Volume fell on the last day by -34 thousand shares and in total, 178 thousand shares were bought and sold for approximately $2.56 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $14.75 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -27.10% during the next 3 months and, with a 90% probability hold a price between $8.28 and $10.75 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
URGN Signals & Forecast
There are mixed signals in the stock today. The UroGen Pharma Ltd stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $14.44. On a fall, the stock will find some support from the short-term average at $14.14. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Monday, April 15, 2024, and so far it has fallen -4.64%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Support, Risk & Stop-loss for UroGen Pharma Ltd stock
UroGen Pharma Ltd finds support from accumulated volume at $14.33 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.760 between high and low, or 5.47%. For the last week, the stock has had daily average volatility of 4.71%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (URGN) For The Upcoming Trading Day Of Thursday 2nd
For the upcoming trading day on Thursday, 2nd we expect UroGen Pharma Ltd to open at $14.31, and during the day (based on 14 day Average True Range), to move between $13.53 and $15.27, which gives a possible trading interval of +/-$0.87 (+/-6.07%) up or down from last closing price. If UroGen Pharma Ltd takes out the full calculated possible swing range there will be an estimated 12.14% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $14.33 (0.49%) than the resistance at $15.10 (4.86%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
UroGen Pharma Ltd will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.93. We will update the financials statements for UroGen Pharma Ltd, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 12.95% in the first trading day after earnings release.
Is UroGen Pharma Ltd stock A Buy?
UroGen Pharma Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -1.874 Sell Candidate Unchanged
Predicted Opening Price for UroGen Pharma Ltd of Thursday, May 2, 2024
| Fair opening price May 2, 2024 | Current price |
|---|---|
| $14.31 ( 0.602%) | $14.40 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for URGN
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 15.07 | 4.68 % | |
| R2 | 14.78 | 2.66 % | ||
| R1 | 14.60 | 1.41 % | ||
| Current price: | 14.40 | |||
| Support | S1 | 14.02 | -2.62 % | |
| S2 | 13.84 | -3.86 % | ||
| S3 | 13.55 | -5.88 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 16.66 | 15.69 % | |
| R2 | 15.76 | 9.44 % | ||
| R1 | 15.10 | 4.86 % | ||
| Current price | 14.40 | |||
| Support | S1 | 14.33 | -0.486% | |
| S2 | 13.82 | -4.03% | ||
| S3 | 13.73 | -4.65% |
FAQ
Click here for our free guide on how to buy UroGen Pharma Ltd Stock.
